Sentence examples for by cost effectiveness from inspiring English sources

But it also said the choice of vaccine should be determined by cost effectiveness, which depends on the negotiated cost of the vaccines.

Execution histories are ordered by cost effectiveness, defined as performance (the exact metric may vary) divided by estimated cost.

The CDC's current HIV prevention program, for example, is focused on risk targeting, bringing a geographic specificity to prevention policies, and developing a rank ordering of policies by cost effectiveness (Centers for Disease Control and Prevention 2009).

Rather than primarily counteracting hypothesis fishing, microarray two-stage analysis is usually motivated by cost effectiveness: By screening out promising candidates first, and then evaluating them, researchers can make a higher number of valuable discoveries for each monetary unit spent.

This article is a joint publication by Cost Effectiveness and Resource Allocation, BJOG: An International Journal of Obstetrics and Gynaecology, BMC Medicine, BMJ, Clinical Therapeutics, The European Journal of Health Economics, International Journal of Technology Assessment in Health Care, Journal of Medical Economics, Pharmacoeconomics and Value in Health.

49 Use of DRV/r in treatment experienced patients is further backed up by cost effectiveness studies, 50, 51 which evaluated treatment costs for HIV RNA reduction (0.5 log reduction) and CD4 count increases (25 cells rise) for boosted darunavir versus other antiretrovirals in treatment experienced patients, using clinical data from POWER and TITAN trials.

Closing secondary schools is cost-effective given a wide range of cost-effective threshold ratios, as shown by cost-effectiveness acceptability curves (Additional file 1: e-Figure 1).

Uncertainty around these estimates is represented by cost-effectiveness acceptability curves, which show the probability that one of the three screening combinations/options is cost-effective compared to a maximum willingness to pay that decision makers might have for these health outcomes, 2 and 3 (for the BRCA1 and BRCA2 groups only)).

Meanwhile, the costs and effects of these markers in clinical practice in China were assessed by cost-effectiveness analysis.

Investments are likely to be driven by cost-effectiveness, regulatory mandates, consumer demand and public interest.

In general, risk abatement within engineering is concerned with minimising both components, with the balance of effort being determined by cost-effectiveness.